US Patent No: 8,142,811

Number of patents in Portfolio can not be more than 2000

Controlled release hydrocodone formulations

Stats

ALSO PUBLISHED AS: 20090202629
See full text
ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PURDUE PHARMA L.P.STAMFORD, CT252

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Hua-Pin Englewood Cliffs, NJ 41 656
Masselink, John K Old Tappan, NJ 17 93
Oshlack, Benjamin New York, NY 183 4140
Tonelli, Alfred P Congers, NY 17 136

Cited Art Landscape

Patent Info (Count) # Cites Year
 
PURDUE PHARMA L.P. (25)
4,828,836 Controlled release pharmaceutical composition 146 1987
4,834,985 Controlled release pharmaceutical composition 175 1987
4,990,341 Controlled release hydromorphone composition 98 1989
5,266,331 Controlled release oxycodone compositions 109 1991
5,273,760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 149 1991
5,286,493 Stabilized controlled release formulations having acrylic polymer coating 147 1992
5,549,912 Controlled release oxycodone compositions 100 1993
5,472,712 Controlled-release formulations coated with aqueous dispersions of ethylcellulose 131 1993
5,580,578 Controlled release formulations coated with aqueous dispersions of acrylic polymers 116 1993
5,478,577 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level 110 1993
5,411,745 Powder-layered morphine sulfate formulations 74 1994
5,965,161 Extruded multi-particulates 81 1994
5,639,476 Controlled release formulations coated with aqueous dispersions of acrylic polymers 288 1995
5,508,042 Controlled release oxycodone compositions 102 1995
5,968,551 Orally administrable opioid formulations having extended duration of effect 111 1995
5,958,459 Opioid formulations having extended controlled released 70 1995
5,656,295 Controlled release oxycodone compositions 87 1996
5,681,585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 71 1996
5,672,360 Method of treating pain by administering 24 hour oral opioid formulations 112 1996
6,143,322 Method of treating humans with opioid formulations having extended controlled release 79 1997
5,958,452 Extruded orally administrable opioid formulations 102 1997
6,103,261 Opioid formulations having extended controlled release 74 1999
6,294,195 Orally administrable opioid formulations having extended duration of effect 77 1999
6,733,783 Controlled release hydrocodone formulations 48 2001
2004/0266,807 Controlled release hydrocodone formulations 11 2004
 
EURO-CELTIQUE S.A. (11)
4,844,907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 110 1986
5,071,646 Pharmaceutical ion exchange resin composition 89 1989
5,356,467 Controlled release coatings derived from aqueous dispersions of zein 111 1993
5,500,227 Immediate release tablet cores of insoluble drugs having sustained-release coating 116 1993
5,670,172 Pharmaceutical spheroid formulation 55 1995
5,849,240 Method of preparing sustained release pharmaceutical compositions 76 1996
5,891,471 Pharmaceutical multiparticulates 70 1996
5,843,480 Controlled release diamorphine formulation 55 1996
5,879,705 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions 71 1997
5,965,163 Substained release compositions and a method of preparing pharmaceutical compositions 80 1997
6,572,885 Orally administrable opioid formulations having extended duration of effect 26 2001
 
ALZA CORPORATION (7)
5,019,397 Aqueous emulsion for pharmaceutical dosage form 65 1988
5,024,842 Annealed coats 70 1990
5,460,826 Morphine therapy 73 1994
6,491,945 Hydrocodone therapy 17 1994
5,593,695 Morphine therapy 29 1995
5,866,161 Hydrocodone therapy 19 1996
5,667,805 Morphine therapy 21 1996
 
Warner-Lambert Company (4)
4,483,847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 66 1983
4,600,645 Process for treating dosage forms 56 1985
5,068,110 Stabilization of enteric coated dosage form 49 1989
5,167,964 Semi-enteric drug delivery systems and methods for preparing same 69 1992
 
ALPHARMA PHARMACEUTICALS, LLC (3)
5,202,128 Sustained release pharmaceutical composition 125 1990
5,330,766 Sustained release pharmaceutical composition 84 1993
5,378,474 Sustained release pharmaceutical composition 96 1993
 
FMC CORPORATION (3)
5,206,030 Film-forming composition and use for coating pharmaceuticals, foods and the like 42 1990
5,248,516 Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like 32 1991
5,258,436 Film-forming composition; method of producing same and use for coating pharmaceuticals and foods and the like 23 1991
 
GACELL LABORATORIES AB (3)
4,557,925 Membrane-coated sustained-release tablets and method 92 1984
5,178,868 Dosage form 54 1991
5,520,931 Controlled release morphine preparation 34 1995
 
DRUGTECH CORPORATION (2)
5,122,384 Oral once-per-day organic nitrate formulation which does not induce tolerance 32 1989
5,133,974 Extended release pharmaceutical formulations 231 1990
 
ELAN CORPORATION, PLC (2)
4,609,542 New pharmaceutical forms for administration of medicaments by oral route, with programmed release 31 1985
5,637,320 Controlled absorption naproxen formulation for once-daily administration 40 1994
 
PURDUE PHARMA COMPANY, THE (2)
4,861,598 Controlled release bases for pharmaceuticals 112 1986
4,970,075 Controlled release bases for pharmaceuticals 91 1989
 
RHODIA INC. (2)
6,264,983 Directly compressible, ultra fine acetaminophen compositions and process for producing same 11 1999
6,607,750 Directly compressible acetaminophen compositions 9 2001
 
VIRGINIA COMMONWEALTH UNIVERSITY (2)
5,321,012 Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance 105 1993
5,502,058 Method for the treatment of pain 87 1994
 
American Cyanamid Company (1)
5,283,065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 74 1992
 
ARCHIMEDES DEVELOPMENT LIMITED (1)
5,629,011 Composition for nasal administration 67 1994
 
ASAHI KASEI CHEMICALS CORPORATION (1)
5,384,130 Spherical seed cores, spherical granules and process for production thereof 41 1993
 
CADBURY ADAMS USA LLC (1)
4,894,234 Novel drug delivery system for antiarrhythmics 70 1988
 
CIBA-GEIGY CORPORATION (1)
4,548,990 Crosslinked, porous polymers for controlled drug delivery 90 1983
 
DepoMed Systems, Inc. (1)
5,007,790 Sustained-release oral drug dosage form 144 1989
 
DEUTSCHE BANK AG NEW YORK BRANCH (1)
4,983,730 Water soluble cellulose acetate composition having improved processability and tensile properties 52 1988
 
Duphar International Research B.V. (1)
5,219,575 Compositions with controlled zero-order delivery rate and method of preparing these compositions 19 1990
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5,169,645 Directly compressible granules having improved flow properties 89 1989
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4,844,909 Controlled release hydromorphone composition 92 1987
 
F.H. FAULDING & CO. LIMITED (1)
5,196,203 Theophylline dosage form 41 1991
 
FISONS CORPORATION (1)
4,959,219 Coating barriers comprising ethyl cellulose 18 1988
 
FOREST LABORATORIES, INC. (1)
4,389,393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 225 1982
 
GLATT GMBH (1)
5,132,142 Apparatus and method for producing pellets by layering power onto particles 47 1991
 
GRUENENTHAL GMBH (1)
5,601,842 Sustained release drug formulation containing a tramadol salt 49 1996
 
Hoechst Aktiengesellschaft (1)
4,935,246 Process for the coating of granules 103 1988
 
MERCK SHARP & DOHME CORP. (1)
4,377,568 Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same 50 1981
 
MERIAL (1)
5,958,425 Viral vaccines 3 1997
 
MERRELL DOW PHARMACEUTICALS INC. (1)
4,421,736 Sustained release diethylpropion compositions 56 1982
 
MILES INC. (1)
4,797,410 Suppression of withdrawal symptoms in opioid-induced tolerance or dependence 31 1987
 
NIPPON SHINYAKU CO., LTD. (1)
5,456,923 Method of manufacturing solid dispersion 100 1993
 
NIRO HOLDING A/S (1)
5,030,400 Process and an apparatus for agglomeration of a powdery material 60 1990
 
PFIZER INC. (1)
4,861,596 Rolled matrix device having enhanced ability to unroll and method for its production 9 1988
 
PHARMACIA & UPJOHN (1)
5,614,218 Controlled release preparation 30 1994
 
PUREUE PHARMA L.P. (1)
4,834,984 Controlled release dihydrocodeine composition 87 1987
 
Richardson-Vicks Inc. (1)
4,996,047 Sustained release drug-resin complexes 66 1988
 
RIJKSUNIVERSITEIT GRONINGEN (1)
4,708,874 Devices for the controlled release of active substances, as well as process for the preparation thereof 56 1986
 
ROHM GMBH (1)
4,520,172 Method for coating medicaments 41 1983
 
SHIN-ETSU CHEMICAL CO., LTD. (1)
4,385,078 Method for providing enteric coating on solid dosage forms and aqueous compositions therefor 66 1979
 
SHIONOGI & CO., LTD. (1)
5,023,089 Sustained-release preparations and the process thereof 48 1989
 
SPRING AG, PHARMAZEUTISCHE PRAEPARATE A SWISS CORP. (1)
5,292,461 Process for the production of pellets 49 1991
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5,026,560 Spherical granules having core and their production 107 1988
 
TCF BANK SAVINGS FSB N/K/A TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 103 1990
 
UCB PHARMA S.A. (1)
6,699,502 Pharmaceutical compositions for controlled release of active substances 14 1999
 
VALEANT INTERNATIONAL BERMUDA (1)
5,518,730 Biodegradable controlled release flash flow melt-spun delivery system 161 1992
 
WATSON LABORATORIES, INC. (1)
4,806,337 Erodible matrix for sustained release bioactive composition 96 1986
 
ZYMA SA (1)
4,728,513 Granular delayed-release form of pharmaceutically active substances 57 1986
 
Other [Check patent profile for assignment information] (2)
4,464,378 Method of administering narcotic antagonists and analgesics and novel dosage forms containing same 125 1981
4,443,428 Extended action controlled release compositions 67 1982

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
PURDUE PHARMA L.P. (1)
8,551,520 Controlled release hydrocodone 0 2012

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 27, 2015
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 27, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 27, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00